KRAS and cancer: Nevertheless, this study is considered preliminary, and future studies to validate the anti-cancer prophylactic and therapeutic efficacy of the live recombinant L. lactis secreting KRAS can be further validated in pre-clinical disease challenge studies with a significantly larger sample size.